Pentara® logo

"We have an End-of-Phase-2 meeting and we don't know what they'll push back on."

Regulatory Support: scientific rigor under pressure

We prepare you for the room. Briefing documents, meeting rehearsal, and live statistical support for FDA interactions, with EMA support where needed, from statisticians who have sat on both sides of the table.

Prepare for your meeting
Agency readiness

The strongest possible scientific argument

Our support includes preparing briefing documents, writing questions, and providing support during critical meetings. We also guide clients on regulatory requirements, ensuring compliance and minimizing risks.

Our expertise is rooted in scientific rigor: every submission is built on sound statistical methodology and independent analysis. We make sure your data not only meets technical requirements but presents the strongest possible scientific argument for efficacy and safety, leveraging deep knowledge in specialized areas like neurodegenerative disease.

  • Briefing document preparation
  • Question strategy and drafting
  • Live support during agency meetings
  • Guidance on regulatory requirements and compliance risk
Two Pentara statisticians on a video call ahead of an FDA meeting, a shared slide on the wall screen
Rescue & remediation

When the first pass hits an obstacle

Whether you face a partial clinical hold, an urgent FDA submission deadline, or preliminary data that requires a strategic pivot, Pentara specializes in study rescue and regulatory remediation. We apply independent statistical oversight to quickly diagnose underlying design flaws, statistical issues, or data deficiencies.

Our urgent response team prepares time-sensitive amendments, delivers rapid data analysis, and crafts the compelling documentation needed to get complex trials back on track and through the regulatory gates, crucial for salvaging significant financial investment and accelerating the delivery of critical therapies.

Partial clinical hold

Rapid diagnosis of the statistical and design issues behind the hold.

Urgent deadline

Time-sensitive amendments and rapid analysis turnaround.

Strategic pivot

Reassessment of outcomes and populations when early data disappoints.

Documentation

Compelling narrative built on defensible methodology.

Talk to the urgent response team →

Tell us what happened and when your deadline is.

Least expensive point to bring us in · Regulatory meeting

Briefing package and anticipated questions. Later, it is a question you can't answer on the day.

See the whole program timeline →
Let's Connect

Walk into the meeting prepared

We'll help you anticipate the questions and answer them with the data you have.